No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
TEVA241213P18000
- 0.70
- +0.04+6.06%
15min DelayClose Dec 11 16:00 ET
0.86High0.70Low
0.86Open0.66Pre Close101 Volume259 Open Interest18.00Strike Price8.67KTurnover59.18%IV0.86%PremiumDec 13, 2024Expiry Date0.55Intrinsic Value100Multiplier2DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.7538Delta0.4158Gamma26.64Leverage Ratio-0.0625Theta-0.0007Rho-20.08Eff Leverage0.0040Vega
Intraday
- 5D
- Daily
News
10 Health Care Stocks Whale Activity In Today's Session
Teva Announces New Patient Access Program With Direct Relief to Provide Access to Inhalers for Uninsured Patients
Medincell Publishes Its Consolidated Half-year Financial Results
Press Release: Medincell Publishes Its Consolidated Half-year Financial Results
Unusual Options Activity: PFE, HSY and Others Attract Market Bets, PFE V/OI Ratio Reaches 167.1
EST Dec 6th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Express News | Takeda Pharmaceutical: selling 49% of the shares in the joint venture with Teva Pharmaceutical Industries, receiving 55 billion yen.